Paclitero 30 mg Injection
$13.01
$3.88
Paclitero 30 mg Injection is an effective chemotherapy treatment utilized in conjunction with other cancer-fighting medications to combat breast cancer, ovarian cancer, and non-small cell lung cancer (NSCLC). This potent injection operates by inhibiting the proliferation of cancer cells, effectively disrupting their ability to divide and multiply, which is crucial for tumor growth. Patients receiving Paclitero should be aware of potential side effects, including fatigue, nausea, and hair loss, which are common with many chemotherapy agents. It is essential to discuss any pre-existing health conditions and current medications with your healthcare provider to ensure safe administration. Regular monitoring during treatment is recommended to manage any adverse reactions effectively. By targeting cancer at the cellular level, Paclitero plays a vital role in modern oncology, offering hope to those battling these aggressive cancers. Always consult your oncologist for personalized advice and to understand how Paclitero can fit into your overall cancer treatment plan.
Quantity
Active Pharmaceutical Ingredient
Uses
• Paclitero 30 mg injection is primarily used in the treatment of non-small cell lung cancer (NSCLC). This medication works by inhibiting the growth of cancer cells, helping to slow disease progression. Patients with advanced NSCLC may benefit from this targeted therapy approach. Its effectiveness makes it a vital option in oncology protocols for managing this type of lung cancer.
• In addition to lung cancer, Paclitero 30 mg injection is also indicated for pancreatic cancer. This aggressive cancer often presents challenges in treatment, and Paclitero offers a therapeutic avenue that may improve outcomes for patients. By interfering with cancer cell division, it helps to manage symptoms and prolong survival. Many oncologists consider it a valuable component of combination therapy in advanced stages.
• Another significant use of Paclitero 30 mg injection is in the management of breast cancer, particularly in cases where the disease is aggressive or has metastasized. The drug targets rapidly dividing cancer cells, contributing to a reduction in tumor size. This can enhance the effectiveness of other treatments, such as surgery or radiation. Patients with certain breast cancer subtypes may find Paclitero to be an essential part of their treatment regimen.
• Paclitero 30 mg injection is often utilized in combination with other chemotherapeutic agents to maximize its efficacy against various cancers. This combination approach can lead to improved overall treatment responses in patients facing complex cancer diagnoses. Oncologists may prescribe Paclitero as part of a personalized treatment plan tailored to the patient's specific cancer type and stage. Its role in multi-drug regimens underscores its importance in modern cancer care.
Benefits
Non-small cell lung cancer: Non-small cell lung cancer is one of the most common types of lung cancer and affects both people who smoke and those who never smoke. Paclitero 30 Injection helps to treat non-small cell lung cancer and may be given alone or combined with other medicines. It is a strong and very toxic medicine. You should discuss the risks and benefits with your doctor. You should drink plenty of water to stay hydrated and avoid alcohol while you are receiving this treatment.
Pancreatic cancer: The pancreas is very important for the digestion of what you eat and also for the metabolism of blood sugar levels, as it produces the body's natural insulin. This medicine will help to control pancreatic cancer and will relieve symptoms such as loss of appetite or unexplained weight loss. Paclitero 30 mg helps stop the action of chemicals that help pancreatic cancer grow and spread. It will help you live longer and healthier.
Breast cancer: Paclitero Injection is used to treat breast cancer. It may be used alone or with other medicines, including chemotherapy. It reduces the symptoms of breast cancer, such as lumpiness in the breast, nipple discharge that is bloody, or changes in the shape or texture of the breast. Paclitero 30 Injection works by killing or stopping the growth of cancer cells and by stopping cancer cells from reproducing in the body. Discuss any side effects with your doctor if they bother you.
Side Effects
Like all medicines, Paclitero 30 may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Hair Loss
• Infections
• Sores in Lips and Mouth
• Anaemia
• Tingling and Burning Sensation in the Hands and Feet
• Bleeding
• Irritation at the site of injection
• Nausea
• Joint and Muscle Pain
• Swelling in hands and feet
Common Side Effects
• Diarrhoea
• Pain in the Stomach
• Problem in Swallowing
• Breathing problems
• Inflammation in Throat, Lips, and Tongue
How To Use
Paclitero Injection is given by intravenous infusion. It is given under the supervision of an experienced nurse or doctor in a clinic or hospital. You should follow all the instructions given to you exactly as prescribed.
Safety Advice
• Alcohol: Drinking alcohol while taking Paclitero 30 Injection is generally not recommended. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol intake while taking any medication.
• Kidney: It is safe to use Paclitero Injection in patients with kidney disease. No dose adjustment of Paclitero 30 mg Injection is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Paclitero 30 Injection. Paclitero 30 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Paclitero 30, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Paclitero 30 mg Injection is safe for use in patients with mild to moderate liver disease; no dose adjustment of Paclitero 30 mg Injection is recommended. The use of Paclitero 30 is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Paclitero 30 Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Paclitero Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Paclitero 30 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Paclitero 30.